Bernhard EJ - Search Results

1

A phase I trial of the dual farnesyltransferase and geranylgeranyltransferase inhibitor L-778,123 and radiotherapy for locally advanced pancreatic cancer.

Martin NE, Brunner TB, Kiel KD, DeLaney TF, Regine WF, Mohiuddin M, Rosato EF, Haller DG, Stevenson JP, Smith D, Pramanik B, Tepper J, Tanaka WK, Morrison B, Deutsch P, Gupta AK, Muschel RJ, McKenna WG, Bernhard EJ, Hahn SM. Martin NE, et al. Among authors: bernhard ej. Clin Cancer Res. 2004 Aug 15;10(16):5447-54. doi: 10.1158/1078-0432.CCR-04-0248. Clin Cancer Res. 2004. PMID: 15328183 Clinical Trial.

2

Local recurrence in head and neck cancer: relationship to radiation resistance and signal transduction.

Gupta AK, McKenna WG, Weber CN, Feldman MD, Goldsmith JD, Mick R, Machtay M, Rosenthal DI, Bakanauskas VJ, Cerniglia GJ, Bernhard EJ, Weber RS, Muschel RJ. Gupta AK, et al. Among authors: bernhard ej. Clin Cancer Res. 2002 Mar;8(3):885-92. Clin Cancer Res. 2002. PMID: 11895923 Clinical Trial.

3

A Phase I trial of the farnesyltransferase inhibitor L-778,123 and radiotherapy for locally advanced lung and head and neck cancer.

Hahn SM, Bernhard EJ, Regine W, Mohiuddin M, Haller DG, Stevenson JP, Smith D, Pramanik B, Tepper J, DeLaney TF, Kiel KD, Morrison B, Deutsch P, Muschel RJ, McKenna WG. Hahn SM, et al. Among authors: bernhard ej. Clin Cancer Res. 2002 May;8(5):1065-72. Clin Cancer Res. 2002. PMID: 12006520 Clinical Trial.

4

Farnesyltransferase inhibitors as radiation sensitizers.

McKenna WG, Muschel RJ, Gupta AK, Hahn SM, Bernhard EJ. McKenna WG, et al. Among authors: bernhard ej. Semin Radiat Oncol. 2002 Jul;12(3 Suppl 2):27-32. doi: 10.1053/srao.2002.34866. Semin Radiat Oncol. 2002. PMID: 12174342 Review.

5

Signaling inhibition with radiation in colorectal cancer: clinical trials.

McKenna WG, Muschel RJ, Gupta A, Hahn S, Bernhard EJ. McKenna WG, et al. Among authors: bernhard ej. Semin Oncol. 2003 Jun;30(3 Suppl 6):56-67. doi: 10.1016/s0093-7754(03)00126-x. Semin Oncol. 2003. PMID: 12802796 Review.

6

Farnesyltransferase inhibitors: an overview of the results of preclinical and clinical investigations.

Brunner TB, Hahn SM, Gupta AK, Muschel RJ, McKenna WG, Bernhard EJ. Brunner TB, et al. Among authors: bernhard ej. Cancer Res. 2003 Sep 15;63(18):5656-68. Cancer Res. 2003. PMID: 14522880 Review.

7

Selective inhibition of Ras, phosphoinositide 3 kinase, and Akt isoforms increases the radiosensitivity of human carcinoma cell lines.

Kim IA, Bae SS, Fernandes A, Wu J, Muschel RJ, McKenna WG, Birnbaum MJ, Bernhard EJ. Kim IA, et al. Among authors: bernhard ej. Cancer Res. 2005 Sep 1;65(17):7902-10. doi: 10.1158/0008-5472.CAN-05-0513. Cancer Res. 2005. PMID: 16140961

8

Pancreatic cancer cell radiation survival and prenyltransferase inhibition: the role of K-Ras.

Brunner TB, Cengel KA, Hahn SM, Wu J, Fraker DL, McKenna WG, Bernhard EJ. Brunner TB, et al. Among authors: bernhard ej. Cancer Res. 2005 Sep 15;65(18):8433-41. doi: 10.1158/0008-5472.CAN-05-0158. Cancer Res. 2005. PMID: 16166322

9

Ras inhibitors and radiation therapy.

Jones HA, Hahn SM, Bernhard E, McKenna WG. Jones HA, et al. Semin Radiat Oncol. 2001 Oct;11(4):328-37. doi: 10.1053/srao.2001.26020. Semin Radiat Oncol. 2001. PMID: 11677657 Review.

10

Farnesyltransferase inhibitors.

Hahn SM, Bernhard E, McKenna WG. Hahn SM, et al. Semin Oncol. 2001 Oct;28(5 Suppl 16):86-93. doi: 10.1016/s0093-7754(01)90286-6. Semin Oncol. 2001. PMID: 11706400 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

114 results

Search Page